ABC: Heart Failure & Cardiomyopathy最新文献

Recurrent Syncope: Initial Presentation of Transthyretin Amyloidosis. Benefits of Disease-Modifying Treatment 复发性晕厥:甲状腺转维蛋白淀粉样变的初始表现。改善疾病治疗的益处

ABC: Heart Failure & Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20210014

E. Correia, Larissa Ventura Ribeiro Bruscky, B. C. O. Valério, A. C. Murta, Fabiano de Castro Albrecht, I. Pinto, P. Smanio

引用次数: 0

Indications for Anticoagulation in Cardiac Amyloidosis 心脏淀粉样变性的抗凝适应症

ABC: Heart Failure & Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20210032

M. W. Montera

{"title":"Indications for Anticoagulation in Cardiac Amyloidosis","authors":"M. W. Montera","doi":"10.36660/abchf.20210032","DOIUrl":"https://doi.org/10.36660/abchf.20210032","url":null,"abstract":"In cardiac amyloidosis, amyloid infiltrate at the atrial level promotes atrial dilation and contractile dysfunction as well as a higher prevalence of atrial fibrillation which, when associated with ventricular diastolic and systolic dysfunction, favors blood stasis and the consequent development of intracardiac thrombosis (ICT) and cardioembolic events. In a study of 116 autopsies of patients with cardiac amyloidosis, conducted at the Mayo Clinic, the presence of ICT was demonstrated in 33% of hearts, with a significantly higher prevalence in patients with the AL form of amyloidosis than in those with other forms (56% versus 16%, p < 0.001).1 When evaluating 324 patients with cardiac amyloidosis using cardiac magnetic resonance, we found an ICT prevalence of 6.2%, with 90% located in the atrial appendage. Among the patients, 70% had atrial fibrillation, and 30% had sinus rhythm, with a similar prevalence of ICT in the AL (5.2%) and ATTR forms (7.2%).2,3 Morphological and functional changes caused by atrial amyloid infiltrate favor the development of atrial fibrillation, with a prevalence ranging from 29% to 60%, depending on the population, and it is more prevalent in the ATTR form, given that it affects an older population. The presence of atrial fibrillation poses a high risk for the development of ICT and stroke, especially in patients with AL amyloidosis.4 Approximately 20% to 30% of patients who have ICT, as well as 27% of patients with cerebral ischemic events are in sinus rhythm.3,5 The probable mechanism respons ib le for the development of thrombotic events and thromboembolism in patients in sinus rhythm would be the presence of atrial myopathy due to amyloid infiltrate and high ventricular filling pressures, which induce atrial contractile dysfunction and favor blood stasis and ICT formation.5-7 By means of logistic regression analysis, several factors have been ident i f ied that are re lated to greater predisposition to ICT and thromboembolic","PeriodicalId":277175,"journal":{"name":"ABC: Heart Failure & Cardiomyopathy","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125764625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Heart Failure with Preserved Ejection Fraction and Cardiac Amyloidosis: Implications for Treatment 保留射血分数和心脏淀粉样变性的心力衰竭:治疗的意义

ABC: Heart Failure & Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20210033

L. C. Danzmann, João Ricardo Cambruzzi Zimmer, Anna Tscheika

引用次数: 2

Registry of Transthyretin Amyloidosis in the State of São Paulo (REACT-SP) 圣保罗州转甲状腺素淀粉样变性登记(REACT-SP)

ABC: Heart Failure & Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20210028

F. Fernandes, C. Cafezeiro, Renata do Val, Alexandra Patrícia Zilli Vieira, Wilson Marques, E. B. Correia, A. Carvalho, A. Chagas, A. Oliveira, P. Souza, W. B. Pinto, A. Macedo, M. Antunes, P. Schwartzmann, S. Mangini, M. Simões

引用次数: 0

Cardiac Amyloidosis and Aortic Stenosis: When to Consider it and How to Treat it? 心脏淀粉样变性和主动脉瓣狭窄:何时考虑和如何治疗?

ABC: Heart Failure & Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20210027

M. Kirschbaum, Aristóteles Conte Alencar, V. E. Rosa, F. Ramires, A. Abizaid, F. Brito, F. Tarasoutchi, R. Kalil, F. Fernandes

引用次数: 0

New Paradigms in Cardiac Amyloidosis: The Current Experience of the Northeast Region of Brazil 心脏淀粉样变性的新模式:巴西东北地区的当前经验

ABC: Heart Failure & Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20210013

T. Silva, C. Montenegro, Marcelo Melo, L. Ritt, André Luiz Cerqueira Almeida

引用次数: 0

The Challenge of HFpEF Diagnosis in Brazil 巴西HFpEF诊断的挑战

ABC: Heart Failure & Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20210011

L. C. Danzmann, E. Belyavskiy, Antônio José Lagoeiro Jorge, E. Mesquita, M. Torres

引用次数: 1

Amyloidosis: Rare or Underdiagnosed Disease? 淀粉样变性:罕见还是未确诊的疾病?

ABC: Heart Failure & Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20210019

M. Llobera, A. Vitali

引用次数: 0

How to Treat Heart Failure in Patients with Cardiac Amyloidosis 如何治疗心脏淀粉样变性患者心力衰竭

ABC: Heart Failure & Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20210031

F. Marcondes-Braga, C. Aragão

引用次数: 0

Cardiac Magnetic Resonance and Amyloidosis: How can it Assist Clinical Reasoning? 心脏磁共振和淀粉样变:如何辅助临床推理?

ABC: Heart Failure & Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20210016

I. Pinto

引用次数: 0